Alliance for Pandemic Preparedness

May 28, 2021

Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection

Category:

Topic:

Keywords (Tags): ,

  • Clinical or subclinical myocarditis associated with SARS-CoV-2 infection was detected in 2.3% of US college athletes with COVID-19 undergoing comprehensive cardiovascular testing from March to December 2020 (n=1597). Only 5 athletes (0.31%) would have been detected based on cardiac symptoms alone, while cardiac magnetic resonance imaging for all athletes yielded a 7.4-fold increase in detection of both clinical and subclinical myocarditis. Prevalence across the 13 participating universities varied from 0%-7.6%, with varying testing protocols closely tied to detection of myocarditis. 

Daniels et al. (May 27, 2021). Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection. JAMA Cardiology. https://doi.org/10.1001/jamacardio.2021.2065